Fate Therapeutics In
FATE
Delayed Nasdaq - 10/20 10:00:00 pm
4.18USD
+1.7%
Upcoming events

- No events available -

Past Events
09/28/17 | 04:00pmLEERINK Partners Rare Disease & Immuno-Oncology Conference
09/26/17 | 04:20pmCantor Fitzgerald Global Healthcare Conference
09/07/17 | 02:15pmWells Fargo Securities Health Care Conference
08/16/17 | 07:20pmWedbush PacGrow Health Care Conference
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
4,40
4,34
1,5%

3,87
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-32,0
-33,4
4,4%

-40,0
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-33,5
-35,0
4,5%

-40,5
Net income
Million $
Released
Forecast
Spread
-33,5
-35,1
4,7%

-40,5
EPS
 $
Released
Forecast
Spread
-1,05
-1,14
8,1%

-0,97
Announcement Date03/16/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread
1,03
0,94
9,5%

0,93
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-9,57
-9,99
4,2%

-10,1
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-9,65
-10,1
4,5%

-10,2
Net income
Million $
Released
Forecast
Spread
-9,65
-10,1
4,4%

-10,2
EPS
 $
Released
Forecast
Spread
-0,23
-0,24
4,2%

-0,24
Announcement Date08/14/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise